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genetic sequences has a fundamental role in the study of a virus
with high sequence variability, such HRSV. This methodology
could also be used for genome sequencing of other RNA viruses.
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Respiratory syncytial virus (RSV) attachment (G) protein mediates
virus binding to cells and is a target for human neutralising anti-
bodies. Understanding its evolutionary patterns is relevant to de-
sign of vaccines or antiviral therapy. RSV group B genotype BA,
characterised by a sixty-nucleotide duplication, was first detected
in 1999 in Buenos Aires, Argentina, and has since been spread
and become the globally dominant RSV B genotype. BA viruses
were first detected in Kilifi, coastal Kenya in 2003 and soon
achieved high prevalence, replacing all other RSV-B genotypes.
We present in detail, evolutionary patterns of the genotype BA G
protein from>600 BA viruses obtained during twelve successive
RSV epidemics in Kilifi. Phylogenetic analyses revealed extensive
diversification of the BA genotype viruses into multiple geneti-
cally distinct variants (58), some of which persisted locally
across sequential epidemics while others were re-introductions
into the community. The most recent common ancestor dated
back to 1990, and the mean evolutionary rate over their G ectodo-
main region was 6.51104 substitutions/site/year (95 per cent CI
5.65–7.42104). Demographic analysis demonstrated two main
phases: an early rapid expansion and subsequent seasonal fluc-
tuations of BA populations. Putative positive selection was de-
tected in six codon sites, all located in the second hyper-variable
G protein region. Nucleotide substitutions introducing alternative
termination codons were observed resulting in up to five different
protein lengths. Two potential N-glycosylation sites were con-
served in 89.3 per cent sampled viruses while eight other sites
were detected in a small proportion of the viruses. Further, four
codons tended to revert to previous states over successive epi-
demics, an indication of adaptive mechanism for immune eva-
sion. These results provide insights into the local genotype BA
viral evolutionary dynamics and highlight the importance of con-
tinuous molecular surveillance to inform on changes in proteins
that may be important to vaccine design.
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In February 2012, the novel respiratory syncytial virus (RSV)
group A, genotype ON1, was detected in Kilifi County, coastal
Kenya. ON1 is characterized by a seventy-two-nt duplication
within the highly variable G gene (encoding the immunogenic
attachment surface protein). Cases were diagnosed through sur-
veillance of pneumonia in children at the county hospital.
Analysis of epidemiologic, clinical, and sequence data of RSV-A
viruses detected over five RSV seasons (2010/2011 to 2014/2015)
indicated the following: 1) replacement of previously circulating
genotype GA2 by ON1, 2) an abrupt expansion in the number of
ON1 variants detected in the 2014/2015 epidemic, 3) recent accu-
mulation of amino acid substitutions within the ON1 duplicated
sequence, and 4) no clear evidence of altered pathogenicity rela-
tive to GA2. The study demonstrates the public health impor-
tance of molecular surveillance in defining the spread, clinical
effects, and evolution of novel respiratory virus variants.
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Respiratory viruses cause a high burden of disease worldwide.
The attributed morbidity and mortality is especially high in in-
fants and young children with lower respiratory tract illness. In
contrast to influenza virus, little is known about the circulation
patterns of other pathogens that commonly cause respiratory
disease in humans, such as respiratory syncytial virus and the
human parainfluenza viruses. The recently proposed source-
sink and globally migrating metapopulation models have im-
proved our understanding of circulation patterns of influenza
virus. We thus aim to investigate the molecular evolution of
non-influenza respiratory viruses and understand their geo-
graphical transmission dynamics by sequencing viruses and
combining them with sequences from public databases.
Temporal phylogenetic trees are then inferred within a
Bayesian framework to characterise the evolutionary and popu-
lation dynamics of these viruses. Finally, we use phylogeo-
graphic methods to infer global migration patterns. For human
parainfluenza virus 3 (HPIV-3), our preliminary analysis indi-
cates that multiple virus lineages co-circulate globally and re-
gionally, with introductions into specific locations that are
followed by expansion and endemic circulation within each
given location. We find that the HPIV-3 phylogeny displays geo-
graphical structuring that may be related to regional outbreaks.
However, HPIV-3 can also be transmitted globally as reflected
by the inter-mixing of different geographical locations.
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Human respiratory syncytial virus (HRSV) is the most common
cause of acute respiratory infection in young children. HRSV be-
longs to the Pneumoviridae family within the order of the
Mononegavirales and can be divided into two subtypes: HRSV-A
and HRSV-B. The two subtypes co-circulate during the annual
HRSV season, which occurs between November and March in
Belgium. The aim of this study was to determine the circulating
HRSV subtypes and genotypes between the seasons of 2011–2012
to 2016–2017. With this information, we intend to understand the
temporal phylogenetic relationships better between the circulat-
ing strains over the six seasons. Between October 2011 and
February 2017, 1,272 HRSV positive patient samples from the
University Hospitals of Leuven were collected. In order to
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